Details

Autor(en) / Beteiligte

• El Morabet, Najla
• Uitvlugt, Elien B.
• van den Bemt, Bart J.F.
• van den Bemt, Patricia M.L.A.
• Janssen, Marjo J.A.
• Karapinar‐Çarkit, Fatma

Titel

Prevalence and Preventability of Drug‐Related Hospital Readmissions: A Systematic Review

Ist Teil von

• Journal of the American Geriatrics Society (JAGS), 2018-03, Vol.66 (3), p.602-608

Ort / Verlag

United States: Wiley Subscription Services, Inc

Erscheinungsjahr

2018

Quelle

Wiley Blackwell Single Titles

Beschreibungen/Notizen

• Objectives To summarize the evidence on the prevalence and preventability of drug‐related hospital readmissions. Design A systematic review was performed of studies that examined drug‐related hospital readmissions. PubMed, EMBASE, and the Cochrane Library were searched from inception through August 2016. Reference lists and a citation analysis on Web of Science and Scopus were also consulted. Two reviewers extracted study data with dual assessment of risk of bias. Prevalence and preventability of readmission due to drugs were calculated. Data were qualitatively summarized according to outcome. Results Nineteen studies met the eligibility criteria. Nine measured readmissions due to drug‐related problems, seven due to adverse drug reactions, two due to adverse drug events, and one due to drug‐drug interactions. Rates of readmissions due to drugs varied from 3% to 64% (median 21%, interquartile range (IQR) 14–23%). Readmissions were deemed preventable in 5% to 87% of cases (median 69%, IQR 19–84%). Evidence regarding the risk factors for drug‐related readmissions and drugs causing these readmissions was inconsistent. Conclusion Although studies show high variability in prevalence and preventability of drug‐related hospital readmissions, readmissions due to drugs seem to occur often, especially in older adults. Further research is needed to specify the causes of preventable readmissions and implement effective interventions to reduce medication‐related hospital admissions.